Sonne DP, Engstrom T, Treiman M: Protective effects of GLP-1 analogues exendin-4 and GLP-1(936) amide against ischemia-reperfusion injury in rat heart
Gut health improvements from oral BPC-157 may take several weeks to manifest fully
The rationale for stacking GHK-Cu vs NAD+ together is additive rather than synergistic: GHK-Cu handles structural repair while NAD+ handles bioenergetics
In clinical trials, around 44 percent of people taking the 2.4-milligram (mg) dose of semaglutide (the highest dose of Wegovy) experienced nausea, as opposed to about 20 percent of people taking a 1-milligram dose of semaglutide
Similarly, the large jump from 1.0mg to 1.7mg can be split into 1.25mg followed by 1.5mg followed by 1.7mg for people with sensitive gastrointestinal systems
But of course, every drug, and especially every blockbuster drug, comes with major questions, such as why do GLP-1s seem to have an impact on such a wide range of ailments